US pharma industry sees a drop of 22.2% in deal activity in July 2019
The US pharma industry saw a drop of 22.2% in overall deal activity during July 2019, when compared with the…
All articles by Baghmar P
Baghmar P
-
-
Pharma industry deals in July 2019 total $4.57bn globally
Total pharma industry deals for July 2019 worth $4.57bn were announced globally, according to GlobalData's deals database. Embed this chart…
-
China’s pharma industry sees a drop of 28.1% in deal activity in Q2 2019
China's pharma industry saw a drop of 28.1% in overall deal activity during Q2 2019, when compared with the last…
-
North America’s pharma industry sees a drop of 10.3% in deal activity in Q2 2019
North America's pharma industry saw a drop of 10.3% in overall deal activity during Q2 2019, when compared to the…
-
Europe’s pharma industry sees a rise of 1.2% in deal activity in Q2 2019
Europe's pharma industry saw a rise of 1.2% in overall deal activity during Q2 2019, when compared to the four-quarter…
-
Pharma industry M&A deals in Q2 2019 total $114.8bn globally
Total pharma industry M&A deals in Q2 2019 worth $114.8bn were announced globally, according to GlobalData's deals database. Embed this…
-
Pharma industry venture financing deals in Q2 2019 total $2.72bn in US
Total pharma industry venture financing deals in Q2 2019 worth $2.72bn were announced in the US, according to GlobalData's deals…
-
Pharma industry deals in Q2 2019 total $121.51bn globally
Total pharma industry deals for Q2 2019 worth $121.51bn were announced globally, according to GlobalData's deals database. Embed this chart…
-
Pharma industry private equity deals in Q2 2019 total $2.98bn globally
Total pharma industry private equity deals in Q2 2019 worth $2.98bn were announced globally, according to GlobalData's deals database. Embed…
-
Pharma industry venture financing deals in Q2 2019 total $3.72bn globally
Total pharma industry venture financing deals in Q2 2019 worth $3.72bn were announced globally, according to GlobalData's deals database. Embed…